U.S. regulator OKs Eisai-Biogen Alzheimer's drug's continuous dosing

This is good if indeed it will neutralize the disease or slow it down. It is just a terrible sickness.

Japan needs these drugs yesterday!

Continuous dosing requirement problematic with the patient group I would think .

"Did i dose today ? Oh well, I will have another just in case "

Continuous dosing requirement problematic with the patient group I would think .

"Did i dose today ? Oh well, I will have another just in case "

The treatment is done intravenously in the hospital (every two or four weeks) so this would not be a problem unless everybody involved (doctor, nurses, etc.) have the same problem as the patient.

The question remains, how much will this drug cost and how much will the Japanese National Health Insurance pay and how much has the patient to pay....

I doubt that every old person living on a small retirement allowance is able to pay even 10 percent of the costs.

GuruMickToday  10:38 am JST

Continuous dosing requirement problematic with the patient group I would think .

"Did i dose today ? Oh well, I will have another just in case "

Actually No. if this is done as an I.V at hospital, the nurse or doc would do it. So i don't see any reason for an missed dosages.

YohanToday  07:08 pm JST

The question remains, how much will this drug cost and how much will the Japanese National Health Insurance pay and how much has the patient to pay....

I doubt that every old person living on a small retirement allowance is able to pay even 10 percent of the costs.

I think we will be able to negotiate a price deal with the companies to bring the costs down.

The question remains, how much will this drug cost and how much will the Japanese National Health Insurance pay and how much has the patient to pay....

...and does it work, does it provide any benefit?

...and does it work, does it provide any benefit?

The FDA says it does according to data from clinical trials and more than one year of use by the public.